病毒感染Discovery and development of kibdelomycin, a new class of broad-spectrum antibiotics targeting the clinically proven bacterial type II topoisomerase.
期刊:Bioorganic & medicinal chemistry发表年份:2016作者:Sheo B Singh
追踪行业前沿,洞察产业趋势